Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection

MeSH terms

• Antiviral Agents / therapeutic use*
• Antiviral Agents / toxicity*
• Arabinofuranosyluracil / analogs & derivatives*
• Arabinofuranosyluracil / therapeutic use
• Arabinofuranosyluracil / toxicity
• Clinical Trials, Phase I as Topic
• Clinical Trials, Phase II as Topic
• Hepatitis B / blood
• Hepatitis B / drug therapy*
• Humans
• Lactates / blood
• Liver Transplantation
• Randomized Controlled Trials as Topic